Bone Marrow TransplantationHematopoietic Stem Cell TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone and BonesStem CellsHematopoietic Stem CellsWhole-Body IrradiationLiver TransplantationPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalLeukemiaHematologic NeoplasmsBusulfanAnemia, AplasticHistocompatibility TestingTreatment OutcomeBone Marrow PurgingKidney TransplantationBone Marrow DiseasesHistocompatibilityRecurrenceCyclophosphamideHematopoiesisCombined Modality TherapyTransplantation, IsogeneicRemission InductionBone Marrow ExaminationImmunosuppressive AgentsCell DifferentiationMice, Inbred C57BLTime FactorsLeukemia, Myeloid, AcuteBone RemodelingMesenchymal Stem Cell TransplantationCord Blood Stem Cell TransplantationBone Marrow NeoplasmsMultiple MyelomaCell TransplantationRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft RejectionTransplantation ImmunologyHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationRadiation ChimeraSurvival AnalysisMelphalanMyelodysplastic SyndromesLymphoma, Non-HodgkinImmunosuppressionAntigens, CD34Lymphocyte DepletionGraft vs Leukemia EffectColony-Forming Units AssayLung TransplantationHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsLeukemia, MyeloidHLA AntigensAcute DiseaseCells, CulturedT-LymphocytesSurvival RateMyeloablative AgonistsBone DensityHematopoietic Stem Cell MobilizationLymphocyte TransfusionDisease-Free SurvivalFlow CytometryGranulocyte Colony-Stimulating FactorGraft vs Tumor EffectSevere Combined ImmunodeficiencyOrgan TransplantationFollow-Up StudiesEmbryonic Stem CellsCytarabineBone ResorptionCyclosporineCytomegalovirus InfectionsChimeraChimerismLeukocyte TransfusionGraft vs Host ReactionCarmustineCell LineageMesenchymal Stromal CellsAdult Stem CellsEtoposidePrognosisCell SeparationSalvage Therapy